Qiming Corporate GP VI, Ltd. sold $5.5M of Alamar Biosciences (ALMR)

Executed Oct 30, disclosed Nov 3, 4 days later.

Value, as filed

$5.5M

180,649 sh across 10 lots

Executed

Oct 30

the trade date, as filed

Disclosed

Nov 3

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

QL Qiming Corporate GP VI, Ltd. 10% owner profile →

Qiming Corporate GP VI, Ltd. (10% owner) filed 7 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 7 sales), most often in Alamar Biosciences, Inc. (ALMR). The largest single filing was $10.0M of ALMR (334,750 sh across 16 lots, as filed), executed Oct 21.

The name

ALMR

Alamar Biosciences, Inc. ALMR · Healthcare · 9 filings in 24 months ticker →

Healthcare · Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and service…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Qiming Corporate GP VI, Ltd. in ALMR

ALMRSALE Alamar Biosciences, Inc. $3.3M
109,367 sh across 3 lots
Exec Nov 3
Filed Nov 5 · 4:10 PM ET ALMRSALE Alamar Biosciences, Inc. $5.8M
179,941 sh across 13 lots
Exec Oct 27
Filed Oct 29 · 4:09 PM ET ALMRSALE Alamar Biosciences, Inc. $8.4M
273,415 sh across 10 lots
Exec Oct 23
Filed Oct 27 · 4:10 PM ET ALMRSALE Alamar Biosciences, Inc. $10.0M
334,750 sh across 16 lots
Exec Oct 21
Filed Oct 23 · 7:35 PM ET ALMRSALE Alamar Biosciences, Inc. $5.6M
203,527 sh across 8 lots
Exec Oct 19
Filed Oct 21 · 7:15 PM ET ALMRSALE Alamar Biosciences, Inc. $4.7M
170,013 sh across 3 lots
Exec Oct 15
Filed Oct 19 · 4:30 PM ET